Literature DB >> 33669313

Pharmacological and Metabolic Significance of Bile Acids in Retinal Diseases.

Alice Win1, Amanda Delgado1, Ravirajsinh N Jadeja2,3, Pamela M Martin1,2,3, Manuela Bartoli1,3, Menaka C Thounaojam1,3.   

Abstract

Bile acids (BAs) are amphipathic sterols primarily synthesized from cholesterol in the liver and released in the intestinal lumen upon food intake. BAs play important roles in micellination of dietary lipids, stimulating bile flow, promoting biliary phospholipid secretion, and regulating cholesterol synthesis and elimination. Emerging evidence, however, suggests that, aside from their conventional biological function, BAs are also important signaling molecules and therapeutic tools. In the last decade, the therapeutic applications of BAs in the treatment of ocular diseases have gained great interest. Despite the identification of BA synthesis, metabolism, and recycling in ocular tissues, much remains unknown with regards to their biological significance in the eye. Additionally, as gut microbiota directly affects the quality of circulating BAs, their analysis could derive important information on changes occurring in this microenvironment. This review aims at providing an overview of BA metabolism and biological function with a focus on their potential therapeutic and diagnostic use for retinal diseases.

Entities:  

Keywords:  TUDCA; UDCA; bile acids; gut microbiota; ocular diseases

Mesh:

Substances:

Year:  2021        PMID: 33669313      PMCID: PMC7920062          DOI: 10.3390/biom11020292

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  116 in total

1.  Activity of single neurons in monkey cortex preceding sensory cued limb movements.

Authors:  M Godschalk
Journal:  Electroencephalogr Clin Neurophysiol Suppl       Date:  1991

2.  Constituents of bile, bilirubin and TUDCA, protect against oxidative stress-induced retinal degeneration.

Authors:  Brian C Oveson; Takeshi Iwase; Sean F Hackett; Sun Young Lee; Shinichi Usui; Thomas W Sedlak; Solomon H Snyder; Peter A Campochiaro; Jennifer U Sung
Journal:  J Neurochem       Date:  2010-12-02       Impact factor: 5.372

3.  Tool from ancient pharmacopoeia prevents vision loss.

Authors:  Jeffrey H Boatright; Anisha G Moring; Clinton McElroy; Michael J Phillips; Vi T Do; Bo Chang; Norm L Hawes; Amber P Boyd; Sheree S Sidney; Rachael E Stewart; Steven C Minear; Rajashree Chaudhury; Vincent T Ciavatta; Cecilia M P Rodrigues; Clifford J Steer; John M Nickerson; Machelle T Pardue
Journal:  Mol Vis       Date:  2006-12-29       Impact factor: 2.367

4.  Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene.

Authors:  B Chang; N L Hawes; M T Pardue; A M German; R E Hurd; M T Davisson; S Nusinowitz; K Rengarajan; A P Boyd; S S Sidney; M J Phillips; R E Stewart; R Chaudhury; J M Nickerson; J R Heckenlively; J H Boatright
Journal:  Vision Res       Date:  2007-01-30       Impact factor: 1.886

Review 5.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 6.  The solute carrier family SLC10: more than a family of bile acid transporters regarding function and phylogenetic relationships.

Authors:  J Geyer; T Wilke; E Petzinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-16       Impact factor: 3.000

Review 7.  Bile acid metabolism and signaling.

Authors:  John Y L Chiang
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

8.  Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30.

Authors:  M Joe Phillips; Tiffany A Walker; Hee-Young Choi; Amanda E Faulkner; Moon K Kim; Sheree S Sidney; Amber P Boyd; John M Nickerson; Jeffrey H Boatright; Machelle T Pardue
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05       Impact factor: 4.799

Review 9.  Substitutes for Bear Bile for the Treatment of Liver Diseases: Research Progress and Future Perspective.

Authors:  Sha Li; Hor Yue Tan; Ning Wang; Ming Hong; Lei Li; Fan Cheung; Yibin Feng
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-21       Impact factor: 2.629

10.  How Ocular Surface Microbiota Debuts in Type 2 Diabetes Mellitus.

Authors:  Siqi Li; Guoguo Yi; Hui Peng; Zhenhao Li; Shuze Chen; Huimin Zhong; Yifan Chen; Zhoucheng Wang; Qixin Deng; Min Fu
Journal:  Front Cell Infect Microbiol       Date:  2019-06-17       Impact factor: 5.293

View more
  3 in total

1.  Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.

Authors:  Zongyi Wang; Jiyang Tang; Enzhong Jin; Chi Ren; Siying Li; Linqi Zhang; Yusheng Zhong; Yu Cao; Jianmin Wang; Wei Zhou; Mingwei Zhao; Lvzhen Huang; Jinfeng Qu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-08       Impact factor: 6.055

Review 2.  Dysfunctional peroxisomal lipid metabolisms and their ocular manifestations.

Authors:  Chuck T Chen; Zhuo Shao; Zhongjie Fu
Journal:  Front Cell Dev Biol       Date:  2022-09-07

3.  Psychiatric Comorbidities and Liver Injury Are Associated With Unbalanced Plasma Bile Acid Profile During Methamphetamine Withdrawal.

Authors:  Yuru Ma; Hongjin Wu; Huawei Wang; Fengrong Chen; Zhenrong Xie; Zunyue Zhang; Qingyan Peng; Jiqing Yang; Yong Zhou; Cheng Chen; Minghui Chen; Yongjin Zhang; Juehua Yu; Kunhua Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.